Verrica Pharmaceuticals (VRCA) Short Interest Ratio & Short Volume $0.69 -0.01 (-0.97%) (As of 11:24 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Verrica Pharmaceuticals Short Interest DataVerrica Pharmaceuticals (VRCA) has a short interest of 3.04 million shares. This marks a -32.59% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.5, indicating that it would take 3.5 days of the average trading volume of 491,860 shares to cover all short positions.Current Short Interest3,040,000 sharesPrevious Short Interest4,510,000 sharesChange Vs. Previous Month-32.59%Dollar Volume Sold Short$3.89 millionShort Interest Ratio3.5 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares45,601,000 sharesPercentage of Shares Shorted6.67%Today's Trading Volume181,865 sharesAverage Trading Volume491,860 sharesToday's Volume Vs. Average37% Short Selling Verrica Pharmaceuticals? Sign up to receive the latest short interest report for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVRCA Short Interest Over TimeVRCA Days to Cover Over TimeVRCA Percentage of Float Shorted Over Time Ad WealthPressIs the Trump/Musk duo good for shares of TSLA?If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Verrica Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20243,040,000 shares $3.89 million -32.6%N/A3.5 $1.28 11/15/20244,510,000 shares $3.76 million +3.2%16.6%4.7 $0.83 10/31/20244,370,000 shares $6.12 million -3.5%16.1%4 $1.40 10/15/20244,530,000 shares $6.30 million +24.8%17.4%4.7 $1.39 9/30/20243,630,000 shares $5.26 million +11.7%13.9%3.9 $1.45 9/15/20243,250,000 shares $6.40 million +9.1%12.5%4.7 $1.97 Get the Latest News and Ratings for VRCA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20242,980,000 shares $7.00 million -28.9%11.5%4.6 $2.35 8/15/20244,190,000 shares $12.19 million +13.6%16.2%9.3 $2.91 7/31/20243,690,000 shares $24.32 million -6.8%14.3%15.4 $6.59 7/15/20243,960,000 shares $33.15 million +1.3%15.4%17.1 $8.37 6/30/20243,910,000 shares $28.50 million +9.5%15.2%18 $7.29 6/15/20243,570,000 shares $28.99 million +0.9%13.9%16.5 $8.12 5/31/20243,540,000 shares $30.13 million -7.8%13.7%18.2 $8.51 5/15/20243,840,000 shares $34.94 million +6.1%14.9%20.2 $9.10 4/30/20243,620,000 shares $25.21 million -5.7%14.1%23.6 $6.97 4/15/20243,840,000 shares $26.57 million -8.1%15.1%28.3 $6.92 3/31/20244,180,000 shares $24.75 million -5.0%16.5%28.2 $5.92 3/15/20244,400,000 shares $21.12 million -0.7%17.4%22.4 $4.80 2/29/20244,430,000 shares $23.35 million +1.1%17.4%4.1 $5.27 2/15/20244,380,000 shares $24.35 million -1.1%17.3%4.1 $5.56 1/31/20244,430,000 shares $25.03 million -20.2%17.7%4.1 $5.65 1/15/20245,550,000 shares $31.75 million +5.3%22.1%5.1 $5.72 12/31/20235,270,000 shares $38.58 million +44.4%21.0%4.9 $7.32 12/15/20233,650,000 shares $22.23 million -8.5%14.6%3.4 $6.09 11/30/20233,990,000 shares $14.68 million -6.3%15.9%25 $3.68 11/15/20234,260,000 shares $13.50 million +1.2%17.0%23.9 $3.17 10/31/20234,210,000 shares $15.49 million -2.3%16.7%21.7 $3.68 10/15/20234,310,000 shares $15.73 million -3.8%17.1%15.1 $3.65 9/30/20234,480,000 shares $17.40 million -9.3%17.8%11.8 $3.89 9/15/20234,940,000 shares $20.01 million +1.9%19.6%12.6 $4.05 8/31/20234,850,000 shares $22.07 million +7.5%19.3%11.5 $4.55 8/15/20234,510,000 shares $22.50 million +11.1%17.8%11.1 $4.99 7/31/20234,060,000 shares $23.71 million +34.4%16.0%10.7 $5.84 7/15/20233,020,000 shares $20.20 million +3.8%12.0%9.4 $6.69 6/30/20232,910,000 shares $16.79 million +33.5%11.5%13.3 $5.77 6/15/20232,180,000 shares $13.67 million +6.9%8.6%10.6 $6.27 5/31/20232,040,000 shares $11.57 million +14.6%8.1%13.4 $5.67 5/15/20231,780,000 shares $10.86 million +21.1%7.1%10.9 $6.10 4/30/20231,470,000 shares $9.07 million +55.7%5.9%7.6 $6.17 4/15/2023944,100 shares $5.85 million +60.7%3.8%4.9 $6.202025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] 3/31/2023587,500 shares $3.82 million +94.8%2.4%3 $6.50 3/15/2023301,600 shares $2.01 million +24.8%1.2%1.7 $6.65 2/28/2023241,600 shares $1.87 million -7.5%1.0%1.4 $7.75 2/15/2023261,200 shares $1.97 million +12.1%1.1%1.6 $7.54 1/31/2023233,000 shares $1.08 million -50.7%1.0%1.7 $4.62 1/15/2023472,500 shares $2.29 million -18.4%2.0%4.2 $4.85 12/30/2022579,300 shares $1.59 million -7.9%2.4%5.9 $2.75 12/15/2022629,000 shares $1.98 million -4.2%2.6%8.1 $3.14 11/30/2022656,300 shares $2.13 million -5.7%2.7%6.6 $3.25 11/15/2022695,800 shares $1.59 million +6.0%2.9%7.1 $2.28 10/31/2022656,300 shares $1.63 million +7.0%2.7%6.5 $2.49 10/15/2022613,200 shares $1.67 million -1.9%2.6%5.7 $2.73 9/30/2022625,100 shares $1.83 million -19.6%2.6%4.5 $2.92 9/15/2022777,900 shares $2.96 million -9.8%3.2%2.4 $3.80 8/31/2022862,400 shares $3.38 million -10.1%3.7%2.6 $3.92 8/15/2022958,800 shares $3.75 million -8.7%4.1%1.8 $3.91 7/31/20221,050,000 shares $3.31 million +5.0%7.0%1.9 $3.15 7/15/20221,000,000 shares $3.21 million -16.7%6.6%1.8 $3.21 6/30/20221,200,000 shares $2.30 million -30.2%8.0%2.2 $1.92 6/15/20221,720,000 shares $3.82 million -5.0%11.1%4.6 $2.22 5/31/20221,810,000 shares $3.49 million -0.6%11.7%5.6 $1.93 5/15/20221,820,000 shares $10.30 million +3.4%11.7%15.3 $5.66 4/30/20221,760,000 shares $11.56 million +8.6%11.3%22.4 $6.57 4/15/20221,620,000 shares $12.83 million +5.2%10.4%23.9 $7.92 3/31/20221,540,000 shares $12.49 million +0.7%9.9%26.6 $8.11 3/15/20221,530,000 shares $12.19 million +2.0%9.9%27 $7.97 2/28/20221,500,000 shares $12.57 million -6.3%9.7%24 $8.38 2/15/20221,600,000 shares $13.41 million +2.6%10.3%23.8 $8.38 1/31/20221,560,000 shares $12.78 million +6.9%11.1%24.5 $8.19 1/15/20221,460,000 shares $12.15 million +2.1%11.1%23.3 $8.32 12/31/20211,430,000 shares $13.10 million +2.1%10.9%23.4 $9.16 12/15/20211,400,000 shares $13.19 million +6.9%10.6%20.5 $9.42 11/30/20211,310,000 shares $13.56 million No Change9.9%11.5 $10.35 11/15/20211,310,000 shares $15.77 million -0.8%9.9%10.6 $12.04 10/29/20211,320,000 shares $16.62 million -2.9%10.0%10.5 $12.59 10/15/20211,360,000 shares $18.17 million -8.1%10.3%11 $13.36 9/30/20211,480,000 shares $18.50 million -21.3%11.2%12.1 $12.50 9/15/20211,880,000 shares $22.15 million -2.1%14.2%15.4 $11.78 8/31/20211,920,000 shares $21.50 million -3.0%14.6%24.6 $11.20 8/13/20211,980,000 shares $21.27 million -2.9%15.1%24.9 $10.74 7/30/20212,040,000 shares $21.83 million No Change15.6%24.2 $10.70 7/15/20212,040,000 shares $21.11 million -1.5%14.0%22.3 $10.35 6/30/20212,070,000 shares $23.39 million +2.0%14.2%21.1 $11.30 6/15/20212,030,000 shares $23.97 million +24.5%13.9%18.6 $11.81 5/28/20211,630,000 shares $18.35 million +8.0%11.1%14.4 $11.26 5/14/20211,510,000 shares $17.62 million +1.3%10.3%14.4 $11.67 4/30/20211,490,000 shares $19.37 million +4.9%10.2%14.1 $13.00 4/15/20211,420,000 shares $19.31 million +17.4%9.7%12.6 $13.60 3/31/20211,210,000 shares $16.55 million +8.0%8.8%10.9 $13.68 3/15/20211,120,000 shares $18.96 million -24.3%7.7%11.2 $16.932025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] 2/26/20211,480,000 shares $21.02 million +0.7%10.8%17.3 $14.20 2/12/20211,470,000 shares $21.42 million -4.6%10.7%19.1 $14.57 1/29/20211,540,000 shares $18.26 million -3.8%11.2%19 $11.86 1/15/20211,600,000 shares $18.86 million -3.6%12.6%20.8 $11.79 12/31/20201,660,000 shares $19.87 million -2.9%13.0%25.5 $11.97 12/15/20201,710,000 shares $16.86 million -8.1%13.5%24.8 $9.86 11/30/20201,860,000 shares $17.52 million +8.1%14.7%24.2 $9.42 10/30/20201,860,000 shares $14.17 million -21.2%14.7%10.9 $7.62 10/15/20202,360,000 shares $19.33 million -7.5%18.7%11.8 $8.19 9/30/20202,550,000 shares $19.74 million +38.6%20.2%11.3 $7.74 9/15/20201,840,000 shares $16.50 million +5.8%14.6%7.7 $8.97 8/31/20201,740,000 shares $15.99 million -3.9%13.8%7.6 $9.19 8/14/20201,810,000 shares $11.89 million +13.1%14.3%8.8 $6.57 7/31/20201,600,000 shares $10.50 million +53.9%12.4%12.5 $6.56 7/15/20201,040,000 shares $8.81 million +25.2%8.1%10.9 $8.47 6/30/2020830,400 shares $11.68 million +59.7%6.5%11.3 $14.07 6/15/2020520,100 shares $6.20 million +5.6%4.0%9.5 $11.92 5/29/2020492,700 shares $5.66 million -36.0%3.8%8.2 $11.48 5/15/2020769,500 shares $7.84 million +0.5%6.0%12.5 $10.19 4/30/2020765,500 shares $9.24 million +1.4%6.0%12.3 $12.07 4/15/2020754,900 shares $8.75 million -5.3%5.9%11.1 $11.59 3/31/2020797,100 shares $8.71 million +1.1%6.2%11.8 $10.93 3/13/2020788,100 shares $8.40 million +7.8%6.2%10.4 $10.66 2/28/2020730,800 shares $5.84 million +23.0%5.7%11 $7.99 2/14/2020594,100 shares $6.05 million +1.8%4.7%7.9 $10.18 1/31/2020583,800 shares $7.57 million -2.6%4.8%7.7 $12.97 1/15/2020599,400 shares $8.76 million +4.6%4.9%7.8 $14.61 12/31/2019573,300 shares $8.77 million -10.7%4.7%7.9 $15.29 VRCA Short Interest - Frequently Asked Questions What is Verrica Pharmaceuticals' current short interest? Short interest is the volume of Verrica Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 3,040,000 shares of VRCA short. Learn More on Verrica Pharmaceuticals' current short interest. What is a good short interest ratio for Verrica Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRCA shares currently have a short interest ratio of 4.0. Learn More on Verrica Pharmaceuticals's short interest ratio. Is Verrica Pharmaceuticals' short interest increasing or decreasing? Verrica Pharmaceuticals saw a decline in short interest during the month of November. As of November 30th, there was short interest totaling 3,040,000 shares, a decline of 32.6% from the previous total of 4,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Verrica Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Verrica Pharmaceuticals: Vaxart, Inc. (4.92%), Cabaletta Bio, Inc. (9.21%), InflaRx (0.27%), Cassava Sciences, Inc. (35.67%), Applied Therapeutics, Inc. (12.19%), Aligos Therapeutics, Inc. (11.17%), Editas Medicine, Inc. (19.46%), Inventiva S.A. (0.67%), Acumen Pharmaceuticals, Inc. (3.09%), Leap Therapeutics, Inc. (4.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Verrica Pharmaceuticals stock? Short selling VRCA is an investing strategy that aims to generate trading profit from Verrica Pharmaceuticals as its price is falling. VRCA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Verrica Pharmaceuticals? A short squeeze for Verrica Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRCA, which in turn drives the price of the stock up even further. How often is Verrica Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRCA, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies VXRT Short Squeeze CABA Short Squeeze IFRX Short Squeeze SAVA Short Squeeze APLT Short Squeeze ALGS Short Squeeze EDIT Short Squeeze IVA Short Squeeze ABOS Short Squeeze LPTX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRCA) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verrica Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verrica Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
